Sort
78,016 grants matching “breast cancer”
Wide-Field Quantitative Fluorescence Imaging System
$1,012,560David W Roberts · Insight Surgical Technologies Inc. · R44 · FY2022 · CA
Elucidating the molecular and contextual basis for IDLE ultralow risk lesions and the tumor immune microenvironment of high risk in situ and invasive breast cancers
$1,012,533Laura J Esserman · University Of California, San Francisco · U01 · FY2019 · CA
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
$1,012,470Suresh Ambudkar · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Statistical Methods in Disease Risk Assessment and Prediction
$1,012,247Shanshan Zhao · National Institute Of Environmental Health Sciences · ZIA · FY2018 · ES
Genetic Epidemiology of Cancer
$1,011,986Joan E. Bailey-Wilson · National Human Genome Research Institute · ZIA · FY2020 · HG
CHEMOPREVENTION OF BREAST AND OVARIAN CANCER
$1,011,836Baylor College Of Medicine · U19 · FY2002 · CA
Determining the Fate of Transmembrane Proteins
$1,011,521Allan M Weissman · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Liver Cancer Disparities in Alaska Native and American Indian People
$1,011,489George Ioannou · University Of Washington · P20 · FY2021 · CA
Development of TIMP-2 derivatives or strategies as biologic therapies for cancer
$1,011,465William Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Breast, Colorectal, and Ovary Cancer Clinical Validation Center
$1,011,430Christopher I Li · Fred Hutchinson Cancer Research Center · U01 · FY2016 · CA
Breast-cancer focused biomarker characterization center employing targeted mass spec assays in a CLIA environment
$1,011,318Amanda G Paulovich · Fred Hutchinson Cancer Center · U2C · FY2024 · CA
Phase I Clinical Testing of a First-in-Class Therapy against Metastatic Cancer
$1,011,207Zdravka O. Medarova · Transcode Therapeutics, Inc. · R44 · FY2024 · CA
Clinical Oncology Program Biostatistical Center
$1,011,136Joseph P. Costantino · University Of Pittsburgh At Pittsburgh · U10 · FY2007 · CA
TRUNCATED GLIOMA-ASSOCIATED ONCOGENE HOMOLOG 1 (TGLI1) IS A NOVEL MEDIATOR AND TARGET FOR BREAST CANCER BRAIN METASTASIS
$1,010,673Wake Forest University Health Sciences · · FY2019 · Defense Health Agency
Epidemiology and Natural History of Cancer-Associated Viruses
$1,010,365Sam M Mbulaiteye · Division Of Cancer Epidemiology And Genetics · ZIA · FY2017 · CA
Leadership, Planning and Evaluation
$1,010,352Alan Ashworth · University Of California, San Francisco · P30 · FY2025 · CA
Stem Cell Biology, Cancer Stem Cell Biology, and Cancer Immunotherapy
$1,010,214Irving Lerner Weissman · Stanford University · R35 · FY2018 · CA
Center for Big Data in Translational Genomics
$1,010,185David H Haussler · University Of California Santa Cruz · U54 · FY2018 · HG
Fast Acousto-Optic Tomography System
$1,010,121Paul Shnitser · Physical Optics Corporation · R44 · FY2011 · CA
DNA Sequencing
$1,009,684Steven Akiyama · National Institute Of Environmental Health Sciences · Z01 · FY2008 · ES
Medical University of South Carolina NCORP Minority/Underserved Community Site
$1,009,670Chanita A Hughes-Halbert · Medical University Of South Carolina · UG1 · FY2018 · CA
Endogenous hormones and postmenopausal breast cancer: Etiologic insights and improving risk prediction
$1,009,278Susan E. Hankinson · University Of Massachusetts Amherst · R01 · FY2017 · CA
Nuclear Factor-kappaB in Ovarian Cancer
$1,009,250Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Cancer Center Core Support Grant
$1,009,128Norman Edward Sharpless · Univ Of North Carolina Chapel Hill · P30 · FY2015 · CA
University of Pennsylvania Patient-derived Xenograft Development and Trials Center
$1,009,106Martin Carroll · University Of Pennsylvania · U54 · FY2024 · CA